This is where precision becomes paramount
We dont know how the prices of novel GLP-1s will change, we dont know what new GLP-1s will be introduced, we dont know how many generics there will be, we dont know how many people will ultimately use them, we dont know how long people will stay on them, we dont know what Medicare drug price negotiations will do to the price, and we dont even know if reducing obesity impacts long-term health spending
Of importance, JM has an eGFR of 50 mL/min/1.73 m 2 with evidence of microalbuminuria
In US POINTER, the improvements were equivalent to approximately one to two years of cognitive advantage, which came alongside other benefits, including reducing frailty and sleep apnoea and improving blood pressure control
Thats when you start to feel fatigued, foggy, and off-balance